Accueil › Cancer métastatique › Connecticut › New Haven
Essais cliniques pour Cancer métastatique à New Haven, CT
23 études pour Cancer métastatique recherchent des participants dans et autour de New Haven (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Recrutement en coursPhase 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- Yale Cancer Center, New Haven
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Recrutement en coursPhase 1
- Yale - New Haven Hospital, New Haven
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
Recrutement en coursPhase 1/2
- Yale Cancer Center-Yale University, New Haven
A Study of ASP3082 in Adults With Advanced Solid Tumors
Recrutement en coursPhase 1
- Smilow Cancer Center at Yale New Haven Hospital, New Haven
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Recrutement en coursPhase 3
- Research Site, New Haven
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recrutement en coursPhase 3
- Yale-New Haven Hospital, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Yale University School of Medicine, New Haven
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Recrutement en coursPhase 2
- Yale University, New Haven
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Recrutement en coursPhase 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Recrutement en coursPhase 3
- Smilow Cancer Hospital at Yale New Haven, New Haven
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- Yale Cancer Center, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Yale University School of Medicine, New Haven
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Recrutement en coursPhase 1/2
- Crinetics Study Site, New Haven
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Recrutement en coursPhase 1/2
- Yale University, New Haven
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Recrutement en coursPhase 1
- Yale University Cancer Center, New Haven
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Exelixis Clinical Site #4, New Haven
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Recrutement en coursPhase 1
- Smilow Cancer Hospital (Yale University), New Haven
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Recrutement en coursPhase 1
- Yale University, New Haven
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Recrutement en coursPhase 1/2
- Yale School of Medicine, North Haven · à 7 mi
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Recrutement en coursPhase 3
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Recrutement en coursPhase 3
- Yale Cancer Center, New Haven
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Recrutement en coursPhase 1
- Yale Cancer Center, New Haven
Essais pour Cancer métastatique dans d'autres villes
- Houston, TX104 études
- New York City, NY93 études
- Nashville, TN70 études
- Boston, MA63 études
- Los Angeles, CA57 études
- St. Louis, MO54 études
- Arlington, VA53 études
- Philadelphia, PA46 études
- Chicago, IL45 études
- San Antonio, TX44 études
- Washington, DC43 études
- Dallas, TX42 études
Autres études à New Haven
- Cancer du poumon non à petites cellules41 études
- Cancer du sein38 études
- Cancer (tous types)33 études
- Cancer du poumon22 études
- Carcinome épidermoïde de la tête et du cou22 études
- Cancer de l'ovaire21 études
- Cancer colorectal20 études
- Cancer de la prostate20 études
- Leucémie aiguë myéloïde17 études
- Trouble de l'usage de l'alcool (TUA)17 études
- Surdose d'opioïdes17 études
- Cancer du pancréas16 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.